Neil Bodick

2018

In 2018, Neil Bodick earned a total compensation of $1.4M as Chief Scientific Officer and Co-Founder at Flexion Therapeutics, a 100% increase compared to previous year.

Compensation breakdown

Bonus$137,120
Option Awards$578,632
Salary$428,500
Stock Awards$223,100
Other$36,438
Total$1,403,790

Bodick received $578.6K in option awards, accounting for 41% of the total pay in 2018.

Bodick also received $137.1K in bonus, $428.5K in salary, $223.1K in stock awards and $36.4K in other compensation.

Rankings

In 2018, Neil Bodick's compensation ranked 7,492nd out of 14,244 executives tracked by ExecPay. In other words, Bodick earned more than 47.4% of executives.

ClassificationRankingPercentile
All
7,492
out of 14,244
47th
Division
Manufacturing
2,910
out of 5,762
50th
Major group
Chemicals And Allied Products
1,092
out of 2,125
49th
Industry group
Drugs
923
out of 1,814
49th
Industry
Pharmaceutical Preparations
725
out of 1,388
48th
Source: SEC filing on April 26, 2019.

Bodick's colleagues

We found four more compensation records of executives who worked with Neil Bodick at Flexion Therapeutics in 2018.

2018

Michael Clayman

Flexion Therapeutics

Chief Executive Officer

2018

David Arkowitz

Flexion Therapeutics

Chief Financial Officer

2018

Mark Levine

Flexion Therapeutics

General Counsel

2018

Scott Kelly

Flexion Therapeutics

Chief Medical Officer

News

You may also like